Fundraising FoxCircle Pharma
South San Francisco, US · Founded 2012 · Delaware corporation · 11 known investors
Find your way into Circle Pharma
Sign up to see every warm intro you have to Circle Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Circle Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
Founders & leadership
Circle Pharma was founded in 2012 by Matthew P. Jacobson and Scott R. Lokey.
Board
Investors · 11
How we know: the VCSheet dataset · Not right? Tell us
How we know: Hemisphere Ventures LLC's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Jude Gomila's portfolio page · Not right? Tell us
How we know: Lifeforce Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Mission Biocapital's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Nextech Invest's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pandect Bioventures's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: racap.com · Not right? Tell us
How we know: The Column Group's portfolio page · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$177.6M disclosed across 4 rounds · 2016–2024
▶$92.4MraisedJan 2025 · 14 investors · OtherRule 506(b)
- Thilo SchroederDirector
- Stephen KelseyDirector
- David J. EarpExecutive Officer, Director
- Matthew P. JacobsonDirector
- Walter H. MoosDirector
- Paul ParkExecutive Officer
- James EvangelistaDirector
- John JoseyDirector
- Offering amount
- $117.4M
- Amount sold
- $92.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$66.3MraisedMar 2022 · 20 investors · PharmaceuticalsRule 506(b)
- James EvangelistaDirector
- Thilo SchroederDirector
- John JoseyDirector
- Matthew JacobsonDirector
- Elton SatuskyExecutive Officer
- David EarpExecutive Officer, Director
- Walter MoosDirector
- Offering amount
- $66.3M
- Amount sold
- $66.3M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedMar 2020 · 7 investors · OtherRule 506(b)
- David J. EarpExecutive Officer, Director
- Elton SatuskyExecutive Officer
- Matthew P. JacobsonDirector
- John JoseyDirector
- Thilo SchroederDirector
- Peter SvennilsonDirector
- Cayla McEwenExecutive Officer
- Walter MoosDirector
- Offering amount
- $45M
- Amount sold
- $15M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedSep 2016 · 4 investors · PharmaceuticalsRule 506(b)
- Scott R. LokeyDirector
- David J. EarpExecutive Officer, Director
- Douglas CrawfordDirector
- Walter MoosDirector
- Matthew JacobsonDirector
- Offering amount
- $6M
- Amount sold
- $3.8M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Circle Pharma.
In the news
Frequently asked questions
- What does Circle Pharma do?
- Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
- Who founded Circle Pharma?
- Circle Pharma was founded by Matthew P. Jacobson, Scott R. Lokey in 2012.
- Who are Circle Pharma's investors?
- Circle Pharma's investors include Berkeley Catalyst, Hemisphere Ventures LLC, Jude Gomila, Lifeforce Capital, Mission Bay Capital, Mission Biocapital, Nextech Invest, Pandect Bioventures and 3 more.
- How much funding has Circle Pharma raised?
- Circle Pharma has disclosed $177.6M raised across 4 rounds.
- Where is Circle Pharma headquartered?
- Circle Pharma is headquartered in South San Francisco, US.